InvestorsHub Logo
Followers 64
Posts 6479
Boards Moderated 0
Alias Born 03/17/2017

Re: TomP1 post# 238158

Monday, 02/24/2020 9:52:26 AM

Monday, February 24, 2020 9:52:26 AM

Post# of 461439

If it is this good for MS, you think BIIB will sit on the drug for 3 years and think about it??



Last 3 years there was hardly any evidence now a little more so yes.

I think they would sit on 273 until there is undeniable evidence and then offer billions rather than now that the paper is published.

Also I think Biogen will not invest in 273 for MS until after they have concluded that their Opicinumab is not working...
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent AVXL News